ChemicalBook > CAS DataBase List > REVEROMYCIN A

REVEROMYCIN A

Product Name
REVEROMYCIN A
CAS No.
134615-37-5
Chemical Name
REVEROMYCIN A
Synonyms
REVEROMYCIN A;ZESGNAJSBDILTB-OXVOKJAASA-N;Butanedioic acid, 1-[(2S,3R,6S,8R,9S)-3-butyl-8-[(2E,4E,6S,7S,8E)-9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrien-1-yl]-2-[(1E,3E)-4-carboxy-3-methyl-1,3-butadien-1-yl]-9-methyl-1,7-dioxaspiro[5.5]undec-3-yl] ester
CBNumber
CB4443481
Molecular Formula
C36H52O11
Formula Weight
660.79
MOL File
134615-37-5.mol
More
Less

REVEROMYCIN A Property

Boiling point:
849.0±65.0 °C(Predicted)
Density 
1.21±0.1 g/cm3(Predicted)
storage temp. 
−20°C
solubility 
DMF: soluble
form 
solid
pka
4.36±0.17(Predicted)
color 
tan
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
R0654
Product name
Reveromycin A
Purity
solid
Packaging
100μg
Price
$350
Updated
2025/07/31
Cayman Chemical
Product number
17458
Product name
Reveromycin A
Purity
≥99%
Packaging
250μg
Price
$353
Updated
2024/03/01
Cayman Chemical
Product number
17458
Product name
Reveromycin A
Purity
≥99%
Packaging
1mg
Price
$704
Updated
2024/03/01
TRC
Product number
R279910
Product name
Reveromycin A
Packaging
250μg
Price
$305
Updated
2021/12/16
Usbiological
Product number
464650
Product name
Reveromycin A
Packaging
100μg
Price
$453
Updated
2021/12/16
More
Less

REVEROMYCIN A Chemical Properties,Usage,Production

Uses

Reveromycin A, the dominant analogue of a complex of spiroketals isolated from a Streptomyces sp., is an inhibitor of the mitogenic activity of EGF. Reveromycin A is a G1 phase cell cycle inhibitor, selectively inhibiting isoleucyl-tRNA synthetase. Reveromycin A displays antiproliferative behaviour against human cell lines KB and K562, as well as potent antifungal activity. More recently it has been shown to induce apoptosis in osteoclasts thus inhibiting bone resorption.

Uses

Reveromycin A is a spiroketal antibiotic inhibitor of EGF mitogenic activity. Inhibits the signal transduction of the epidermal growth factor. May be used

in vivo

Reveromycin A (20 mg/kg; twice daily; i.v.; for 3 days) significantly decreases numbers of OCs without affecting numbers of osteoblasts in normal 4-week-old male Sprague-Dawley rats[2].

REVEROMYCIN A Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

REVEROMYCIN A Suppliers

Alfa Chemistry
Tel
1-516-6625404
Fax
1-516-927-0118
Email
support@alfa-chemistry.com
Country
United States
ProdList
9171
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
52923
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47
LKT Laboratories, Inc.
Tel
--
Fax
--
Email
info@lktlabs.com
Country
United States
ProdList
2164
Advantage
64
A.G. Scientific, Inc.
Tel
--
Fax
--
Email
support@agscientific.com
Country
United States
ProdList
1066
Advantage
71

134615-37-5, REVEROMYCIN ARelated Search:


  • REVEROMYCIN A
  • ZESGNAJSBDILTB-OXVOKJAASA-N
  • Butanedioic acid, 1-[(2S,3R,6S,8R,9S)-3-butyl-8-[(2E,4E,6S,7S,8E)-9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrien-1-yl]-2-[(1E,3E)-4-carboxy-3-methyl-1,3-butadien-1-yl]-9-methyl-1,7-dioxaspiro[5.5]undec-3-yl] ester
  • 134615-37-5
  • C36H52O11
  • BioChemical
  • Antibiotics
  • Antibiotics A to Z
  • Antibiotics N-S
  • Epidermal Growth Factor Receptor (EGFR)Antibiotics
  • Interferes with Protein Synthesis
  • Antibiotics
  • Antibiotics A to
  • Antibiotics by Application
  • Antibiotics N-SAntibiotics
  • AntifungalAntibiotics
  • Mechanism of Action
  • Receptor Tyrosine Kinase Inhibitors
  • Spectrum of Activity
  • Antineoplastic and Immunosuppressive AntibioticsReceptor Tyrosine Kinase Biology